Ecron Acunova-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ecron Acunova - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013182
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ecron Acunova (EA), a subsidiary of Take Solutions Ltd. is a clinical research organization (CRO) serving big pharma companies locally. It offers clinical trial management, clinical data management services. Its services include bioavailability and bioequivalence services, Phase I to IV clinical trials, peri approval studies, PMS, rescue studies, clinical data management and biostatistics, medical writing, regulatory affairs, pharmacovigilance, and central laboratory. Ecron provides bioavailability and bioequivalence services such as consulting, IP import and sample export, protocol design, ethics committee submissions, safety screening and bio analytical testing. The company serves pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. It operates in South East Asia, Central and Nordic Europe and North America. Ecron Acunova is headquartered in Bangalore, Karnataka, India.

Ecron Acunova – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ecron Acunova, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Manipal Acunova Plans To Raise Up To US$30 Million In Venture Financing 11
Partnerships 12
Ecron Acunova Forms Joint venture With Jamjuree Innovations 12
Acquisition 13
TAKE Solutions to Acquire Ecron Acunova 13
Ecron Acunova Acquires Majority Stake In aCROnordic 14
Ecron Acunova – Key Competitors 15
Ecron Acunova – Key Employees 16
Ecron Acunova – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Recent Developments 19
Other Significant Developments 19
Jun 09, 2017: Ecron Acunova to offer end-to-end capabilities as ‘Navitas Life Sciences 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ecron Acunova, Pharmaceuticals & Healthcare, Key Facts 2
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Manipal Acunova Plans To Raise Up To US$30 Million In Venture Financing 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 12
TAKE Solutions to Acquire Ecron Acunova 13
Ecron Acunova Acquires Majority Stake In aCROnordic 14
Ecron Acunova, Key Competitors 15
Ecron Acunova, Key Employees 16
Ecron Acunova, Other Locations 17
Ecron Acunova, Subsidiaries 17
Ecron Acunova, Joint Venture 18

★海外企業調査レポート[Ecron Acunova-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a clinical-stage biopharmaceutical company that develops novel drugs for antibiotic-resistant acne, other skin pathogens and anti-fungal agents in dermatology. The company’s pipeline products include VB 1953, VB 6345, VB 9333 and VB 9450. Its products are …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • BioMarin Pharmaceutical Inc (BMRN)-医療機器分野:企業M&A・提携分析
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals that treat serious diseases and medical conditions. The company offers products for the treatment of various diseases such as Kyndrisa (drisapersen), Duchenne mu …
  • Toyo Engineering Corp:企業の戦略・SWOT・財務分析
    Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report Summary Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fujitsu Australia Ltd:企業の戦略的SWOT分析
    Fujitsu Australia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Safety-Kleen, Inc.:企業の戦略・SWOT・財務分析
    Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • Enel Americas SA:企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sophiris Bio Inc (SPHS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sophiris Bio Inc (Sophiris) is a clinical stage bio-pharmaceutical company, which focuses on developing products for the treatment of urological diseases. Sophiris lead drug candidate, PRX302 is under late stage development for the treatment of lower urinary tract symptoms of benign prostati …
  • ChargePoint Inc:電力:M&Aディール及び事業提携情報
    Summary ChargePoint Inc (ChargePoint), formerly Coulomb Technologies Inc, is a charging network company that designs, builds and supports electric vehicle charging services. The company provides charging stations for electric vehicles. It designs, builds, and supports charging stations of different …
  • Oriental Food Industries Holdings Berhad:企業の戦略・SWOT・財務情報
    Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Habib Insurance Co Ltd (HICL):企業の財務・戦略的SWOT分析
    Habib Insurance Co Ltd (HICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Amica Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Amica Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Amica Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Prime Polymer Co Ltd:企業の戦略的SWOT分析
    Prime Polymer Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Chaparral Energy Inc (CHPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Chaparral Energy Inc (Chaparral Energy) is an oil and gas company that produces crude oil and natural gas. The company’s business activities include exploration, development, production and operation of oil and gas properties and wells in America’s Midwest and Southwest regions. Its new oil …
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • OJSC Surgutneftegas:企業の戦略・SWOT・財務分析
    OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report Summary OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆